GLESSNER COLEEN (EVP, Quality & Ethics, and CPL) reported 1 transaction at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/6/2026ACC: 0001919170-26-000009
Officer· EVP, Quality & Ethics, and CPL
Since Mar 2022
+36.63K
Net shares
Net buyer
$69.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
44.83K acquired · 8.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.20K
Price / share
$8.44
Trade value
$69.20K
% of position
7.3%
3/5/2026
112.31K→104.11K
Total
Net shares
−8.20K
Net value
-$69.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | F · Tax Withholding | −8.20K | $8.44 | $69.20K | 7.3% | 112.31K | 104.11K |
| Total | −8.20K | -$69.20K | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
44.83K shares
Shares
+44.83K
Strike price
8.99
Held after
294.45K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock44.83K shares | 3/3/2026 | A · Award | +44.83K | 8.99 | — | 294.45K |